Search results
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 8 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
Zacks via Yahoo Finance· 2 years agoThe EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via AOL· 8 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 5 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
New data sets stage for broader use of AstraZeneca breast cancer drug
Reuters via Yahoo News· 2 years agoAstraZeneca and Daiichi Sankyo's Enhertu extended survival by more than six months in patients with...
'I'm a people lover': Cancer patient volunteers for clinical trials to help others
Savannah Morning News via Yahoo News· 6 months agoCancer care is constantly improving at Lewis Cancer Research Pavilion and clinical trial...
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
BioPharma Dive via Yahoo Finance· 5 months agoAbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion...
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Zacks via Yahoo Finance· 2 years agoShares of Puma Biotechnology PBYI were up 17.4% at market close on Aug 5, following the earnings...
Roche sceptical about investing more in 'guided-missile' ADC cancer drugs
Reuters via Yahoo News· 2 years agoMANNHEIM (Reuters) -Roche remains sceptical about investing more in antibody-drug conjugates (ADCs),...
'The hope of a fighter': Kennebunk woman runs 10K fundraiser to final chemo treatment
Portsmouth Herald via Yahoo News· 1 year agoWhat's the first thing a person would think to do after completing treatment for cancer? Bet it's...